Attached files
Exhibit 23.1
CONSENT OF REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors
Durata Therapeutics, Inc:
We consent to the use of our report included herein and to the reference to our firm under the heading Experts in the prospectus.
/s/ KPMG LLP
Short Hills, New Jersey
April 30, 2012